1,870
Views
90
CrossRef citations to date
0
Altmetric
Research Article

Development and Physical Characterization of Sorbitan Monoester Niosomes for Insulin Oral Delivery

, , &
Pages 251-262 | Published online: 31 Jan 2011

REFERENCES

  • Arunothayanun, P., Turton, J. A., Uchegbu, I. F., and Florence, A. T. 1999. Preparation and in vitro/in vivo evaluation of luteinizing hormone releas- ing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. J. Pharm .Sci. 88:34–38.
  • Ausborn, M., Nuhn, P., and Schreier, H. 1992. Stabilization of liposomes by freeze-thaw and lyophilization techniques: Problems and opportunities. Eur. J. Biopharm. 38:133–139.
  • Baillie, A. J., Florence, A. T., Hume, L. R., Murihead, G. T., and Rogerson, A. 1985. The preparation and properties of niosomes, non-ionic surfactant vesicles. J. Pharm. Sci. 37:863–868.
  • Baker, R. W., and Lonsdale, H. S. 1974. Controlled release: mechanisms and rates. In Controlled Release of Biologically Active Agents, eds. A. C. Tanquary and R. E. Lacey, 15–71. New York: Plenum Press.
  • Cable, C. 1989. An Examination of the Effects of Surface Modification on the Physiochemical and Biological Properties of Non-Ionic Surfactant Vesicles. Ph.D. thesis. University of Strathclyde, Glasgow, UK.
  • Chung, H., Kim, J., Kwon, I. C., and Jeony, S. Y. 2002. Self-assembled nanocu- bicle as a carrier for peroral insulin delivery. Diabetologia 45:448–451.
  • Damge, C., Vranckx, H., Balschmidt, P., and Couvreur, P. 1997. Poly (alkyl cyanoacrylate) nanospheres for oral administration of insulin. J. Pharm. Sci. 86:1403–1409.
  • Davidson, S. M. K., Carbal-Lilly, D., Maurio, F. P., Franklin, J. C., Minchey, S. R., Ahl, P. L., and Janoff, A. S. 1997. Association and release of prostaglandin E1 from liposomes. Biochim. Biophys. Acta 1327:97–106.
  • De Gier, J., Mandersloot, J. G., and Van Deenen, L. L. M. 1968. Lipid compo- sition and permeability of liposomes. Biochim. Biophys. Acta 150: 666–675.De la Maza, A., Parra, J. L., and Leal, J. S. 1992. Alteration of permeability of neutral and electronegatively charged liposomes by alkyl sulfate surfactants. Langmuir 8:2422–2426.
  • D’Souza, S. A., Ray, J., Pandey, S., and Udupa, N. 1997. Absorption of ciprofloxacin and norfloxacin when administered as niosome-encapsulated inclusion complexes. J. Pharm. Pharmacol. 49:145–149.
  • Fang, J. Y., Hong, C.-T., Chiu, W.-T., and Wang, Y.-Y. 2001. Effect of liposome and niosome on skin permeation of enoxacin. Int. J. Pharm. 219:61–72.
  • Hashimoto, A., and Kawada, J. 1979. Effects of oral administration of posi- tively charged insulin liposomes on alloxan diabetic rats: Preliminary study. Endocrinol. Japan 26:337–344.
  • Hofland, H. E. G., Bouwstra, J. A., Gooris, G. S., Spies, F., Talsma, H., and Juninger, H. E. 1993. Non-ionic surfacatnt vesicles: A study of vesicle for- mation, characterization, and stability. J. Colloid Interface Sci. 161: 336–376.Israelchevili, J. N. 1985. Intermolecular and Surface Forces. Sydney: Academic Press.
  • Inoue, T. 1996. Interactions of surfactants with phospholipid vesicles. In Vesicles, ed. M. Rosoff, 151–195. New York: Marcel Dekker.
  • Iwanaga, K., Ono, S., Narioka, K., Kakemi, M., Morimoto, K., Yamashita, S., Namba, Y., and Oku, N. 1999. Application of surface-coated liposomes for oral delivery of peptide: Effects of coating the liposome’s surface on the GI transit of insulin. J. Pharm. Sci. 88:248–252.
  • Kimura, T., Sato, K., Suigimoto, K., Tao, R., Murakami, T., Kurosoki, Y., and Nakayama, T. 1996. Oral administration of insulin as poly (vinyl alcohol)-gel spheres in diabetic rats. Biol. Pharm. Bull. 19:897–900.
  • Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Avlasov, A. P., Vorob’yov, M. S., Kholodova, E. A., and Zabarovskaya, Z. V. 2001. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: Studies in the rat. Int. J. Pharm. 216:105–114.
  • Kiwada, H., Miimura, H., Fuijisaki, Y., Yamada, S., and Kato, Y. 1985. Applica- tion of synthetic alkyl glycoside vesicles as drug carriers. I. Preparation and physical properties. Chem. Pharm. Bull. 33:735–759.
  • Lai, J. Y., Conald, Chow, D. D., and Hwang, K. J. 1988. Effect of lipid compo- sition on insulin-mediated fusion of small unilamellar liposomes: A kinetic study. J. Pharm. Sci. 77:432–437.
  • Lawrence, M. J., Chauhan, S., Lawrence, S. M., and Barlow, D. J. 1996. The for- mation, characterization and stability of non-ionic surfactant vesicles. S.T.P. Pharma. Sci. 6:49–60.
  • Lehr, C.-M. 1991. Bioadhesive Drug Delivery Systems for Oral Application. Ph.D. thesis, University of Leiden, Leiden, The Netherlands.
  • Lopes de Menezes, D. E., and Vargha-Butler, E. I. 1996. Study of liposomal drug delivery systems, 3. Dynamic in vitro release of steroids from multilamellar liposomes. Colloids Surfaces B: Biointerfaces 6:269–277.
  • Manosori, A., and Bauer, K. H. 1989. The entrapment of human insulin-DEAE dextran complex in different compound liposomes. Drug Dev. Ind. Pharm. 15:2531–2546.
  • Marconi, M., Sinico, C., Valenti, D., Loy, G., and Fadda, A. M. 2002. Niosomes as carriers for tretinoin. I. Preparation and properties. Int. J. Pharm. 234:237– 248.
  • Morishita, M., Morishita, I., Takayama, K., Machida, Y., and Nagai, T. 1992. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int. J. Pharm. 78:1–7.
  • Patel, H. M., Stevenson, R. W., Parsons, J. A., and Ryman, B. E. 1982. Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs. Biochim. Biophys. Acta 716:188–192.
  • Paternostre, M. T., Roux, M., and Riguad, J. L. 1988. Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. I. Solubilization of large unilamellar liposomes (pre- pared by reverse phase evaporation) by Triton X-100, octyl glucoside and sodium cholate. Biochemistry 27:2668–2677.
  • Poste, G. 1983. Liposome targeting in vivo, problems and opportunities. Biol. Cell 47:19–36
  • Rentel, C.-O., Bouwstra, J. A., Naisbett, B., and Juninger, H. E. 1999. Nio- somes as a novel peroral vaccine delivery system. Int. J. Pharm. 186:161– 167.
  • Seras-Cansel, Ollivon, M., and Lesieur, S. 1996. Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles: Evidence of membranen imper- meability to octyl glycoside. S.T.P. Pharma. Sci. 6:12–20.
  • Shao, Z., Li, Y., Krishnamoorthy, R., Chermak, T., and Mitra, A. K. 1993. Differential effects of anionic, cationic, nonionic and physiologic surfactants on the dissociation, chymotryptic degradation and enteral absorption of insulin hexamers. Pharm. Res. 10:243–251.
  • Spangler, R. S., Trebwasser, K. C., and Wilson, M. L. 1986. Effect of charge on hepatic specific nature encapsulated insulin in conscious dogs. Am. J. Physiol. (Endocrinol. Metab.) 14:E591–E596.
  • Tabbakhian, M. 1998. Oral Delivery of Insulin by Polymer-Coated Liposomes. Ph.D. thesis. University of Alberta, Edmonton, Canada.
  • Uchegbu, I. F., and Vyas, S. P. 1998. Non-ionic surfactant based vesicles (nio- somes) in drug delivery. Int. J. Pharm. 172:33–70.
  • Uchegbu, I. F., McCarthy, D., Schatzlein, A., and Florence, A. T. 1996. Phase transitions in aqueous dispersions of the hexadecyl diglycerol ether (C16G2) non-ionic surfactant, cholesterol and cholesteryl poly-24-oxyethylene ether: Vesicles, tubules, discomes and micelles. S.T.P. Pharma. Sci. 6: 33–43.
  • Van Hal, D. A. 1994. Non-Ionic Surfactant Vesicles for Dermal and Transdermal Drug Delivery. Ph.D thesis. University of Leiden, Leiden, The Netherlands. Verhoef, J. C., Bodde, H. E., de Boer, A. G., Bouwstra, J. A., Juninger, H. E., Merkus, F. W. H. M., and Breimer, D. D. 1990. Transport of peptide and protein drugs across biological membranes. Eur. J. Drug Met. Pharm. 15:83–93.
  • Wiener, A. L. 1989. Liposomes as carriers for polypeptides. Adv. Drug Deliv. Rev. 3:307–341.
  • Yoshida, H., Lehr, C. M., Kok, W., Juninger, H. E., Verhoef, J. C., and Bouwstra, J. A. 1992. Niosomes for oral delivery of peptide drugs. J. Control. Rel.21: 145–154.
  • Yoshioka, T., Strenberg, B., and Florence, A. T. 1994. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan riester (Span 85). Int. J. Pharm. 105:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.